glp-1 lymphedema Tirzepatide as a Potential Disease-Modifying Therapy in Lipedema: A Narrative Review on Bridging Metabolism, Inflammation, and Fibrosis The Effects of GLP-1RAs on

CXCL10 is a circulating inflammatory marker in patients with advanced heart failure: a pilot study

Brown Norway rats that did not undergo any treatment (PQ or eye drops) were also included as a healthy untreated control group

however, it was not associated with a reduced CVD risk compared with placebo in patients with T2DM who experienced an acute coronary syndrome event within the previous 180 days ( N = 6068)

Disclosure statement The authors declare that they have no conflict of interest

Weight gain and insulin resistance during nicotine replacement therapy

Women who have metabolic disease in pregnancy have an increased long-term risk of major cardiovascular events, in part because pregnancy unveils underlying endothelial dysfunction [10, 11]